The presence of non-criteria manifestations negatively affects the prognosis of seronegative antiphospholipid syndrome patients: a multicenter study.

dc.contributor.authorPires da Rosa, Gilberto
dc.contributor.authorSousa Pinto, Bernardo
dc.contributor.authorFerreira, Ester
dc.contributor.authorAraújo, Olga
dc.contributor.authorBarilaro, Giuseppe
dc.contributor.authorBettencourt, Paulo
dc.contributor.authorCervera i Segura, Ricard, 1960-
dc.contributor.authorEspinosa Garriga, Gerard
dc.date.accessioned2022-06-09T17:00:56Z
dc.date.available2022-06-09T17:00:56Z
dc.date.issued2022-01-03
dc.date.updated2022-06-09T17:00:56Z
dc.description.abstractBackground: Seronegative antiphospholipid syndrome (SN-APS) is often defned as the presence of APS criteria manifestations, negative antiphospholipid antibodies (aPL), and coexistence of APS non-criteria manifestations. Nevertheless, the impact of these non-criteria features is still unclear. On a diferent note, the relevance of one single aPL positive determination in patients with APS manifestations is another domain with limited evidence. We aim to compare the course of SN-APS and single-positive aPL (SP-aPL) patients with that of individuals with APS manifesta‑ tions without non-criteria features/aPL positivity (controls). Methods: Retrospective analysis of patients with thrombosis/obstetric morbidity assessed in two European hospi‑ tals between 2005 and 2020. Patients were divided into SN-APS, SP-aPL, and control groups. Clinical characteristics, comorbidities, and therapies were compared. Results: A total of 82 patients were included in the SN-APS group, 88 in the SP-aPL group, and 185 in the control group. In Cox regression model, SN-APS displayed more thrombosis recurrence than controls (HR 3.8, 95% CI 2.2-6.5, p<0.001) even when adjusting for the presence of hereditary thrombophilia, systemic lupus erythematosus, or con‑ traceptive hormonal treatment. In SP-aPL, the diference in thrombosis recurrence did not reach statistical signifcance (p=0.078). Indefnite anticoagulation (p<0.001 and p=0.008, respectively) and vitamin K antagonist (VKA) use (p<0.001 in both cases) were more common in SN-APS/SP-aPL. Conclusion: SN-APS displayed more thrombosis recurrence, indefnite anticoagulation, and VKA use than controls without non-criteria manifestations. The presence of such features in patients with thrombosis and negative aPL may negatively impact their clinical course. Keywords: Antiphospholipid syndrome, Antiphospholipid antibodies, Seronegative, Single positive, Non-criteria manifestations
dc.format.extent10 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec719910
dc.identifier.idimarina9295603
dc.identifier.issn1478-6362
dc.identifier.pmid34980238
dc.identifier.urihttps://hdl.handle.net/2445/186526
dc.language.isoeng
dc.publisherBioMed Central
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1186/s13075-021-02702-9
dc.relation.ispartofArthritis Research & Therapy, 2022, vol. 24, num. 1, p. 9
dc.relation.urihttps://doi.org/10.1186/s13075-021-02702-9
dc.rightscc-by (c) Pires da Rosa, Gilberto et al., 2022
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.sourceArticles publicats en revistes (Medicina)
dc.subject.classificationMalalties autoimmunitàries
dc.subject.classificationSíndrome antifosfolipídica
dc.subject.classificationAutoanticossos
dc.subject.classificationLupus eritematós
dc.subject.classificationEmbaràs
dc.subject.otherAutoimmune diseases
dc.subject.otherAntiphospholipid syndrome
dc.subject.otherAutoantibodies
dc.subject.otherLupus erythematosus
dc.subject.otherPregnancy
dc.titleThe presence of non-criteria manifestations negatively affects the prognosis of seronegative antiphospholipid syndrome patients: a multicenter study.
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
719910.pdf
Mida:
1.19 MB
Format:
Adobe Portable Document Format